• DRONEDARONE CHEMBL184412 FDA Approved

    Alternate Names:

    Dronedarone
    METHANESULFONAMIDE, N-[2-BUTYL-3-[4-[3-(DIBUTYLAMINO)PROPOXY]BENZOYL]-5-BENZOFURANYL]-
    DCL000783
    N-(2-BUTYL-3-(4-(3-(DIBUTYLAMINO)PROPOXY)BENZOYL)-5-BENZOFURANYL)-METHANESULFONAMIDE
    CHEBI:50659
    L001445
    141626-36-0
    154087
    AC-5012
    D02537
    METHANESULFONAMIDE, N-(2-BUTYL-3-(4-(3-(DIBUTYLAMINO)PROPOXY)BENZOYL)-5-BENZOFURANYL)-
    SR 33589
    LS-90090
    CID208898
    17396708
    SANOFI-AVENTIS BRAND OF DRONEDARONE
    DRONEDARONE [INN]
    AC1L4LKA
    C118667
    141625-93-6
    DRONEDARONE (INN)
    N-[2-BUTYL-3-{4-[3-(DIBUTYLAMINO)PROPOXY]BENZOYL}-1-BENZOFURAN-5-YL]METHANESULFONAMIDE
    MULTAQ
    SR 33589B
    N-[2-BUTYL-3-[4-[3-(DIBUTYLAMINO)PROPOXY]BENZOYL]-1-BENZOFURAN-5-YL]METHANESULFONAMIDE
    I06-2091
    UNII-JQZ1L091Y2
    N-(2-BUTYL-3-(P-(3-(DIBUTYLAMINO)PROPOXY)BENZOYL)-5-BENZOFURANYL)METHANESULFONAMIDE
    AKOS005145680
    N-[2-BUTYL-3-[4-[3-(DIBUTYLAMINO)PROPOXY]PHENYL]CARBONYL-1-BENZOFURAN-5-YL]METHANESULFONAMIDE
    N-[2-BUTYL-3-[[4-[3-(DIBUTYLAMINO)PROPOXY]PHENYL]-OXOMETHYL]-5-BENZOFURANYL]METHANESULFONAMIDE
    N-[2-BUTYL-3-[4-[3-(DIBUTYLAMINO)PROPOXY]BENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE
    N-(2-BUTYL-3-(4-(3-(DIBUTYLAMINO)PROPOXY)BENZOYL)BENZOFURAN-5-YL) METHANESULFONAMIDE
    2-N-BUTYL 3-[4-(3-DI-N-BUTYLAMINO-PROPOXY)BENZOYL] 5-METHYLSULFONAMIDO BENZOFURAN
    3B2-4718
    A807786
    W-5212
    W3084
    FT-0651916
    AB0022262
    SC-20704
    DR003262
    NCGC00188863-02
    SR33589
    RL01736
    MCULE-5052395136
    DB04855
    CS-0384
    AN-5339
    TOX21_113008_1
    ZINC49933061
    BDBM50151864
    TOX21_113008
    HY-A0016
    ZQTNQVWKHCQYLQ-UHFFFAOYSA-N
    MOLPORT-006-170-000
    HSDB 7928
    C31H44N2O5S
    MET037
    JQZ1L091Y2
    GTPL7465
    SCHEMBL110363
    DRONEDARONE [INN:BAN]
    N-(2-BUTYL-3-{4-[3-(DIBUTYLAMINO)PROPOXY]BENZOYL}-1-BENZOFURAN-5-YL)METHANESULFONAMIDE
    MULTAQREG
    SR-33598B
    CAS-141626-36-0
    DSSTOX_GSID_48653
    DSSTOX_RID_82850
    DSSTOX_CID_28579
    NCGC00188863-01
    208898
    187051768
    7465

    Drug Info:

    FDA Approval 2009
    Drug Class small molecule
    Drug Indications Anti-Arrhythmia Agents
    Drug Class anti-arrhythmia agents
    Year of Approval 2009
    Drug Categories p-glycoprotein/abcb1 inhibitors
    Drug Categories highest risk qtc-prolonging agents
    Drug Categories heterocyclic compounds, 2-ring
    Drug Categories heterocyclic compounds
    Drug Categories cytochrome p-450 cyp3a4 substrates
    Drug Categories cytochrome p-450 cyp3a4 inhibitors (moderate)
    Drug Categories cytochrome p-450 cyp3a inhibitors
    Drug Categories cytochrome p-450 cyp2d6 substrates
    Drug Categories cytochrome p-450 cyp2d6 inhibitors (moderate)
    Drug Categories cytochrome p-450 cyp2d6 inhibitors
    Drug Categories combined inhibitors of cyp3a4 and p-glycoprotein
    Drug Categories cardiovascular system
    Drug Categories cardiac therapy
    Drug Categories bradycardia-causing agents
    Drug Categories benzofurans
    Drug Categories antiarrhythmics, class iii
    Drug Categories antiarrhythmics, class i and iii
    Drug Categories alpha1 antagonists
    Drug Groups approved
    Drug Type small molecule
    (2 More Sources)